{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:40:07Z","timestamp":1756276807858,"version":"3.44.0"},"reference-count":4,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\n                  <jats:bold>Overview of:<\/jats:bold> Sharma V, Simpson SH, Samanani S, <jats:italic>et al<\/jats:italic>. Concurrent use of opioids and benzodiazepine\/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study. <jats:italic>BMJ Open<\/jats:italic> 2020;10:e038692.<\/jats:p>","DOI":"10.1136\/dtb.2021.000038","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T13:27:47Z","timestamp":1625059667000},"page":"116-116","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Risk from concurrent opioid and benzodiazepine use"],"prefix":"10.1136","volume":"59","member":"239","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"key":"2025082622582390000_59.8.116.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038692"},{"key":"2025082622582390000_59.8.116.2","unstructured":"US Food and Drug Administration . New safety measures announced for opioid analgesics, prescription opioid cough products, and benzodiazepines [online], 2016. Available: https:\/\/www.fda.gov\/drugs\/information-drug-class\/new-safety-measures-announced-opioid-analgesics-prescription-opioid-cough-products-and [Accessed 14 Jun 2021]."},{"key":"2025082622582390000_59.8.116.3","unstructured":"European Medicines Agency . Concomitant use of benzodiazepines\/benzodiazepine like products and opioids [online], 2018. Available: https:\/\/www.hma.eu\/fileadmin\/dateien\/Human_Medicines\/CMD_h_\/Advice_from_CMDh\/CMDh_372_2018_Rev0_02_2018.pdf [Accessed 14 Jun 2021]."},{"key":"2025082622582390000_59.8.116.4","first-page":"5","article-title":"Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression","volume":"13","year":"2020","journal-title":"Drug Saf"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2021.000038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T05:58:33Z","timestamp":1756274313000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2021.000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":4,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,7,28]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/dtb.2021.000038"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2021.000038","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2021,6,30]]}}}